Navigation Links
Los Angeles Daily Journal Names Richardson & Patel Verdict Top in the State of California for 2007
Date:1/31/2008

$96 Million Jury Verdict Secured by Business Law Firm That Took on Medical

Malpractice Case for a Child of Firm's Partner

LOS ANGELES, Jan. 31 /PRNewswire/ -- Richardson & Patel, LLP, a business law firm with offices in Los Angeles and New York City announced today that the Los Angeles Daily Journal newspaper named the firm's $96 million judgment against Verdugo Hills Hospital as the largest jury verdict in the State of California for 2007.

Notable on several levels, this verdict was the first medical malpractice case for the firm, which specializes in corporate and securities law. Moreover, the plaintiff, four-year-old Aidan Leung, is the son of partner Kevin Leung, head of the firm's Asia Practice Group.

The case was tried by Luan K. Phan, Richardson & Patel's Managing Partner of Litigation and a Loyola Law School classmate of Mr. Leung. Mr. Phan found himself going head-to-head against top med mal trial firms and walking away with a decisive victory.

Though their work tends toward securities and corporate law matters, Mr. Leung's fellow partners agreed to champion Aidan's case after he suffered severe brain damage from kernicterus, a preventable neurological disorder caused by severe jaundice. The hospital failed to diagnose, warn, or treat Aidan properly and its negligence proved devastating. Aidan cannot walk, talk, sit or stand. He has normal intelligence, but is a prisoner trapped in a body that does not work.

After years of contentious litigation, and six weeks of trial, on July 2, a jury from the conservative Glendale courthouse awarded Aidan over $96 million in future damages, with a present value of $15 million.

"I am a business litigator first and foremost" said Mr. Phan, Managing Partner of Richardson & Patel's Litigation Department. "But when my friend and partner asked me to take on his son's case, I couldn't let him down. We decided as a firm that we would commit ourselves to protect one
'/>"/>

SOURCE Richardson & Patel, LLP
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Cardiac Science Completes Deployment of AEDs With Los Angeles County Fire Department
2. Photo: Two Men Raising Awareness of HIV/AIDS by Running Minimum of a Marathon a Day from San Francisco to Los Angeles
3. Construction Begins on Los Angeles First New Continuing Care Retirement Community Facility in Over a Decade
4. Cookie Johnson and Abbott Bring I Stand With Magic: Campaign to End Black AIDS to Los Angeles to Educate African-American Women on HIV/AIDS
5. Run-in-a-Million Run from San Francisco to Los Angeles to Raise Awareness About AIDS and HIV Testing
6. AIDS Healthcare Foundations Role in the City of Los Angeles HIV Testing Initiative
7. Mayor Antonio Villaraigosa Partners With AltaMed Health Services to Launch City of Los Angeles HIV Testing Initiative
8. Los Angeles Port Pollution, Intl Trade & Goods Movement Conference This Weekend
9. New Gallup Survey Finds Half of Los Angeles Area Residents Have Taken in a Near-Homeless Person, One-Third Fear Homelessness Themselves
10. United Way of Greater Los Angeles and Fannie Mae Foundation Announce 3000 Marchers for HomeWalk 2007
11. Childrens Hospital Los Angeles Turns Off the Tap With Green Earth Waterless Carwash
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2008)...team develops device giving patients freedom of mo...DAY, July 26 (HealthDay News) -- An automated arti...e day be to dialysis patients what the insulin pum...rable artificial kidney (AWAK) works better than c...current issue of Clinical and Experimental Nephro...
(Date:7/25/2008)...AKE SUCCESS, N.Y., July 25 /PRNewswire-USNewswire/...as Chief Quality Officer and Vice President,of Str...monwealth Fund, a,national foundation committed to...e directed the foundation,s Program on Health Care...p://www.newscom.com/cgi-bin/prnh/20080725/DC28791L...
(Date:7/25/2008)...red immune response after antiretroviral therapy m... July 25 (HealthDay News) -- A new study challenge...(HCV) impairs the immune system,s ability to resto...ly active antiretroviral therapy (HAART). , Fro...ers are also infected with HCV. Intravenous drug u...
(Date:7/25/2008)...he Authority offers patients consumers tips and en...ient safety, HARRISBURG, Pa., July 25 /PRNewswire...thority today supports "National Patient Safety Da...s and their families to,participate fully in their...thing they can about their surgery or illness., "...
Breaking Medicine News(10 mins):Health News:IPRO Welcomes Back Anthony Shih as Chief Quality Officer, Strategic Planning Lead 2Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 3
...ngton, in Seattle, a group of engineers has recent... latest creation: a surgical robot// to deploy in ... a remote control console. Military groups all ov... in remote surgery. On the battlefield, medical re...
...Children's Research Hospital have discovered that ...duction of a molecule that is key to the ability//...s to break down toxins, and of cells to extract en...estigators showed that ABCB6 is lodged within the ...
...ide rates among younger and older Americans have b...ling news: No one really knows why// . Those are ...t the University of South Carolina and released Th...tober issue of the American Journal of Public Heal...
...lty members performing microsurgery in Tanzania fr...om, or health care experts// in Vietnam presenting...thered in the Hopkins outpatient center. These are... Internet communication system that will be used f...
Other Medicine News:Health News:Doc at a Distance 2Health News:ABCB6 Is Key to Production of Heme in Hemoglobin 2Health News:Most Suicide Rates Decline, but Findings Are Puzzling 2Health News:Most Suicide Rates Decline, but Findings Are Puzzling 3Health News:High-Speed Internet2 Link Revolutionizes Global Medical Education 2
(Date:7/24/2008)... /PRNewswire-USNewswire/ -- Headlines claiming "so...e story. The small scale,preliminary study that D...duction, is based on recollected intake of soyfood...This study is confounded by many,issues, thus I fe...of,caution," warned Dr. Tammy Hedlund, a researche...
(Date:7/24/2008)...rance, July 24 /- NicOx S.A...ne results from the 52-week,open label safety exte...of,the 301 phase 3 study for naproxcinod. The resu...icacy was maintained for the one-year duration of,...essment scale. In,addition, the results showed tha...
(Date:7/23/2008)... /PRNewswire-USNewswire/ -- The following was,rele... Conyers, Ranking Member Smith, and Members of the...fy today., Since I appeared before this Committee...acquainted with the talented and dedicated profess... they do, and I have come to,appreciate that much ...
(Date:7/23/2008)...RNewswire-FirstCall/ -- Dendreon Corporation,(Nasd...dependent Data,Monitoring Committee (IDMC) to revi... survival relating to the Company,s Phase 3 IMPACT...ent, also known as D9902B) clinical trial,of PROVE...nvestigational,active cellular immunotherapy for t...
Breaking Medicine Technology:Soyfoods Do Not Impact Sperm Count 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 3NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 4Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Steps toward Stopping Autoimmune Disease 1967 1Steps toward Stopping Autoimmune Disease 1967 2CeloNova BioSciences Announces Positive Results from European Study of Embozene 28TM 29 Microspheres for Treatment of Uterine Fibroids 1229 1CeloNova BioSciences Announces Positive Results from European Study of Embozene 28TM 29 Microspheres for Treatment of Uterine Fibroids 1229 2Students Pursuing Health Care Careers Receive 2424 000 in Scholarships From National Hispanic Health Foundation 9799 1Students Pursuing Health Care Careers Receive 2424 000 in Scholarships From National Hispanic Health Foundation 9799 2Solutions for Parents Who Need Cold Remedies for Their Children 9795 1Solutions for Parents Who Need Cold Remedies for Their Children 9795 2
...EGO, May 22, 2007 /PRNewswire/ -- A new study pres...iddle-of-the-night,balance, mobility or memory per...o placebo. This study also demonstrated, as in,pre... did have,impaired performances on these measures,...e-blind, placebo-controlled trial were,presented i...
... Release of Data for New Combination , , , , , P...cium channel blocker,amlodipine besylate with the ... produced significant mean reductions in,seated sy...th,hypertension, according to data presented at th...Second Annual Scientific Meeting and,Exposition (A...
Other Medicine Technology:New Study Suggests no Significant Impairment in Middle-of-the-Night,Balance, Mobility or Memory in Older Adults Using Ramelteon 2New Study Suggests no Significant Impairment in Middle-of-the-Night,Balance, Mobility or Memory in Older Adults Using Ramelteon 3New Study Suggests no Significant Impairment in Middle-of-the-Night,Balance, Mobility or Memory in Older Adults Using Ramelteon 4Amlodipine and Olmesartan Study Results Released;Late Breaker,Presented at American Society of Hypertension Twenty-Second Annual,Scientific Meeting (ASH 2007) 2Amlodipine and Olmesartan Study Results Released;Late Breaker,Presented at American Society of Hypertension Twenty-Second Annual,Scientific Meeting (ASH 2007) 3Amlodipine and Olmesartan Study Results Released;Late Breaker,Presented at American Society of Hypertension Twenty-Second Annual,Scientific Meeting (ASH 2007) 4
Meter Trax Control is a whole blood quality control that can be used for glucose, hemoglobin and hematocrit testing on point of care instruments.
Liquichek Qualitative Urine Toxicology Control is a liquid control designed for use with qualitative rapid urine drug screen panels, including Point of Care (POC) Drugs of Abuse (DOA) test kits like
Liquichek Sedimentation Rate Control is a bilevel human whole blood based control designed to monitor both manual and automated methods for measuring erythrocyte sedimentation rates.
Liquichek Hematology-16 Control is specifically designed for use on most hematology analyzers that measure up to 16 parameters and 3-part white blood cell differentials. This trilevel control can be
Medicine Products: